Wired-GOV Newswire (news from other organisations)
BIA and MHRA publish report following joint conference Pathway of Innovation from Research to Patients
UK BioIndustry Association (BIA) and the Medicines and Healthcare products Regulatory Agency (MHRA) report following their fifth joint annual conference.
The UK BioIndustry Association (BIA) and the Medicines and Healthcare products Regulatory Agency (MHRA) today publish a report following their fifth joint annual conference, Pathway of Innovation from Research to Patients, held on 11 June at the Wellcome Trust.
The event, which was attended by over 140 delegates from patients’ groups, MHRA, the National Institute for Biological Standards and Control, the life science industry, the Wellcome Trust, the Jenner Institute, academic institutions and clinical trial units, showcased the collaborative approaches between stakeholders to support innovation and to facilitate clinical development and timely access to new treatments and vaccines for patients.
Key topics of discussion included the value of a patient-centered approach in informing and accelerating drug development and lessons learnt from the unprecedented response to the recent Ebola epidemic. Establishing a patient-centred system for drug development requires a co-ordinated effort, which the UK is well placed to achieve with strong patients’ groups becoming increasingly involved in regulatory processes, health technology assessments and commissioning decisions.
The newly published report provides an overview of key discussions from the conference and a resulting set of recommendations.
Commenting on the publication of the report, Steve Bates, BIA CEO, said:
”Following another successful joint conference with the MHRA, the publication of our first report from the event will provide a great lasting resource for SMEs, increasing awareness of the potential impact that patient engagement could have on regulatory pathways.”
Dr Christiane Abouzeid, Head of Regulatory Affairs, BIA, commented:
”The annual BIA/MHRA conference provides an excellent opportunity for the exchanging of expertise between regulators and industry, now extended through the publication of our joint report.”
Dr Siu Ping Lam, Director, Licensing Division, MHRA, said:
”This was a hugely productive conference. It is increasingly recognised that patients have a key role to play in regulatory decisions. This goes to the heart of MHRA’s mission of encouraging, supporting and enabling innovation.
We will continue to use our scientific and regulatory expertise to advise industry and make drug development programmes as efficient as possible, facilitating safe and timely patient access.”
The fifth annual joint BIA/MHRA conference was held on 11 June 2015 at the Wellcome Trust in London.
- BIA MHRA conference report: Pathway of innovation from Research to Patients
- BIA MHRA conference website
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe. All our work is underpinned by robust and fact-based judgements to ensure that the benefits justify any risks. MHRA is a centre of the Medicines and Healthcare products Regulatory Agency which also includes NIBSC and CPRD. The Medicines and Healthcare products Regulatory Agency is an executive agency of the Department of Health. www.gov.uk/mhra
151 Buckingham Palace Road
During office hours:020 3080 7651
Out of office hours:07770 446 189
Office hours are Monday to Friday, 9am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at twitter.com/mhrapress
Established over 25 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK’s position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people’s lives. For further information, please go to www.bioindustry.org and twitter.com/BIA_UK
Jess Gray, Communications Executive
Phone: 020 7630 2197
Latest News from
Wired-GOV Newswire (news from other organisations)
CBI NI responds to latest review of covid restrictions14/05/2021 16:38:00
CBI NI yesterday responded to latest review of covid restrictions.
Work from Home Day: new laws needed to make flexible working patterns available for all workers after pandemic14/05/2021 14:05:00
Today (Friday) is the 16th annual Work from Home Day, organised by Work Wise UK as part of Work Wise Week – a week of activity to promote employment practices that improve work-life balance.
CBI Wales responds to latest relaxation of COVID-19 restrictions14/05/2021 12:15:00
CBI Wales yesterday responded to latest relaxation of COVID-19 restrictions.
Business and government must stand united to tackle great challenges of the age – G7 business groups14/05/2021 09:05:00
Leading business federations issue communique backed UK by Prime Minister ahead of G7 leaders’ meeting next month in Cornwall.
TUC: Yorkshire still facing job losses and shrinking economy despite national GDP growth13/05/2021 16:05:00
Commenting on yesterday’s (Wednesday) GDP figures, showing a reduction of 1.5% for the first quarter of 2021 overall but a rise of 2.1% in March, the TUC urged caution based on regional data showing sustained negative growth and job losses across the region.
LGA responds to DEFRA’s Action Plan for Animal Welfare13/05/2021 14:40:00
Cllr Nesil Caliskan, Chair of the LGA’s Safer and Stronger Communities Board, commented on Rural Affairs’ Action Plan for Animal Welfare
NHS Confederation - Lessons from COVID inquiry must translate into action13/05/2021 13:40:00
Danny Mortimer, chief executive of the NHS Confederation, commented on the announcement of a public inquiry into COVID-19
LGA responds to ending of ban on eviction enforcement13/05/2021 12:40:00
Cllr David Renard, Local Government Association housing spokesperson, responded to the announcement of the ending of the current ban on bailiff-enforced evictions on 31 May
CBI responds to release of Q1 GDP figures13/05/2021 12:15:00
CBI yesterday responded to release of Q1 GDP figures.
Audit Scotland - Accounts Commission for Scotland and Improvement Service collaboration focused on improving local government services13/05/2021 11:40:00
The Accounts Commission and the Improvement Service have confirmed a formal collaboration focused on accelerating the improvement and pace of change in local government services.